See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2013_Assertio_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 95,267,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 25,078,000 |
| 2 | PropertyPlantAndEquipmentNet | 8,237,000 |
| 3 | remainder_Assets | 13,071,000 |
| 4 | LiabilitiesCurrent | 36,681,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 97,646,000 |
| 9 | ResearchAndDevelopmentExpense | 15,462,000 |
| 10 | remainder_Expenses | 7,970,000 |
| 11 | remainder_Revenues | 90,816,000 |
| 12 | remainder_NetIncome | 481,000 |
| 13 | remainder_ComprehensiveNetIncome | 44,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 141,653,000 |
| 1 | Liabilities | 36,681,000 |
| 2 | Expenses | 121,078,000 |
| 3 | Revenues | 90,816,000 |
| 4 | StockholdersEquity | 104,972,000 |
| 5 | NetIncome | -29,781,000 |
| 6 | ComprehensiveNetIncome | -29,759,000 |
| 7 | BaseVar | 195,376,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.23 |
| 9 | EconomicCapitalRatio | 3.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
